Use of nitric oxide-releasing agents to treat impotency

US5910316A · kind A · utility

Assignees

• The United States of America, as represented by the Department of Health and Human Services · US
• Vivus, Inc. · US

Inventors

• Larry K. Keefer · Bethesda, US
• Joseph E. Saavedra · Thurmont, US
• Paul C. Doherty, Jr. · Cupertino, US
• Mark S. Hanamoto · Mill Valley, US
• Virgil A. Place · Kawaihae, US

Key dates

• Filing date: Apr 10, 1995
• Grant date: Jun 8, 1999
• Expiry date: Apr 10, 2015

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C08F8/32
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A method of treatment for impotency is provided. The method involves the administration of nitric oxide by a nitric oxide-releasing agent capable of providing a penile erection-inducing amount of nitric oxide to the corpus cavernosum of the penis of an impotent male animal. Also provided is a nitric oxide delivery means for use in the method.